Literature DB >> 16932244

Graves' hyperthyroidism: how long should antithyroid drug therapy be continued to achieve remission?

Anthony P Weetman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16932244     DOI: 10.1038/ncpendmet0068

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN: 1745-8366


× No keyword cloud information.
  8 in total

Review 1.  Controversies in the management of Graves' disease in children.

Authors:  S A Rivkees
Journal:  J Endocrinol Invest       Date:  2016-05-06       Impact factor: 4.256

Review 2.  Management of thyroid disorders.

Authors:  L D K E Premawardhana; J H Lazarus
Journal:  Postgrad Med J       Date:  2006-09       Impact factor: 2.401

3.  "Block-and-replace" treatment in Graves' disease: experience in a cohort of pediatric patients.

Authors:  M C Vigone; E Peroni; M Di Frenna; S Mora; G Barera; G Weber
Journal:  J Endocrinol Invest       Date:  2019-11-12       Impact factor: 4.256

Review 4.  Indefinite antithyroid drug therapy in toxic Graves' disease: What are the cons.

Authors:  Rajesh Rajput; Vasudha Goel
Journal:  Indian J Endocrinol Metab       Date:  2013-10

5.  Guidelines for the treatment of childhood-onset Graves' disease in Japan, 2016.

Authors:  Kanshi Minamitani; Hirokazu Sato; Hidemi Ohye; Shohei Harada; Osamu Arisaka
Journal:  Clin Pediatr Endocrinol       Date:  2017-04-22

Review 6.  Hyperthyroidism in childhood: causes, when and how to treat.

Authors:  Juliane Léger; Jean Claude Carel
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013

Review 7.  Pediatric Graves' disease: management in the post-propylthiouracil Era.

Authors:  Scott A Rivkees
Journal:  Int J Pediatr Endocrinol       Date:  2014-06-16

8.  [Difficulties in managing Graves' disease in children: about a case].

Authors:  Nassiba Elouarradi; Ghizlane El Mghari; Nawal El Ansari
Journal:  Pan Afr Med J       Date:  2018-06-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.